Genetic and phenotypic characterisation of <scp>HIV</scp>‐associated aggressive B‐cell <scp>non‐Hodgkin</scp> lymphomas, which do not occur specifically in this population: diagnostic and prognostic implications
Maria João Baptista(Josep Carreras Leukaemia Research Institute), José‐Tomás Navarro(Universitat Autònoma de Barcelona), Alejandra Martínez‐Trillos(Aristotle University of Thessaloniki), Silvia Montoto(Queen Mary University of London), Fina Climent, Luis Veloza(Hospital Clínic de Barcelona), José Luís Mate(Universitat Autònoma de Barcelona), Javier Menárguez, Miguel Alcoceba(Instituto de Investigación Biomédica de Salamanca), Maria Calaminici(Queen Mary University of London), Carlos García‐Ballesteros(Hospital Arnau de Vilanova), Eva González‐Barca(Institut Català d'Oncologia), Javier Briones(Hospital de Sant Pau), María José Terol(Hospital Clínico Universitario de Valencia), Antonio Martı́nez(Hospital Universitario de Móstoles), John G. Gribben(Queen Mary University of London), Ana Muntañola(University Hospital Mútua de Terrassa), José M. Moraleda(Centro Regional de Hemodonación), Antonio Ferrández(INCLIVA Health Research Institute), Gustavo Tapia(Hospital Universitari Germans Trias i Pujol), Eugènia Abella(Hospital Del Mar), Juan‐Manuel Sancho(Hospital Universitari Germans Trias i Pujol), Josep‐María Ribera(Universitat Autònoma de Barcelona), Mariano Provencio(Hospital Universitario Puerta de Hierro Majadahonda), Ana M Muñoz‐Mármol(Universitat Autònoma de Barcelona), Montserrat Garcia‐Caro(Hospital de Mataró), Lluı́s Colomo(Hospital Del Mar), Olga García(Universitat Autònoma de Barcelona), Josep Muncunill(Universitat Autònoma de Barcelona), Teresa Aldámiz, Pau Abrisqueta(Universitat Autònoma de Barcelona)
Cited by 13
Related Papers
Erlotinib versus standard chemotherapy as first-line treatment for European patients with advanced EGFR mutation-positive non-small-cell lung cancer (EURTAC): a multicentre, open-label, randomised phase 3 trial
|The Lancet Oncology|2012|5.5k
Screening for Epidermal Growth Factor Receptor Mutations in Lung Cancer
|New England Journal of Medicine|2009|2.4k
Stromal Gene Signatures in Large-B-Cell Lymphomas
|New England Journal of Medicine|2008|1.8k